<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: How Did the Vaccine Cross the Road?</title>
	<atom:link href="http://scienceprogress.org/2009/08/influenza-vaccine/feed/" rel="self" type="application/rss+xml" />
	<link>http://scienceprogress.org/2009/08/influenza-vaccine/</link>
	<description></description>
	<lastBuildDate>Tue, 13 Sep 2011 13:59:48 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
	<item>
		<title>By: Erwin D. Ferri</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-7033</link>
		<dc:creator>Erwin D. Ferri</dc:creator>
		<pubDate>Wed, 07 Apr 2010 07:13:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-7033</guid>
		<description>i find this of utmost interest.  I do hope these alternative methods have been put forth.  I commend you for your insight.</description>
		<content:encoded><![CDATA[<p>i find this of utmost interest.  I do hope these alternative methods have been put forth.  I commend you for your insight.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: John Hubbell</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6075</link>
		<dc:creator>John Hubbell</dc:creator>
		<pubDate>Wed, 16 Sep 2009 04:46:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6075</guid>
		<description>Cel Sci (CVM) is developing a H1N1 vaccine using its L.E.A.P.S. technology along the lines of what is described as &quot;conserved regions&quot; in the above article.</description>
		<content:encoded><![CDATA[<p>Cel Sci (CVM) is developing a H1N1 vaccine using its L.E.A.P.S. technology along the lines of what is described as &#8220;conserved regions&#8221; in the above article.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Tanya Silva MD</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6031</link>
		<dc:creator>Tanya Silva MD</dc:creator>
		<pubDate>Wed, 02 Sep 2009 20:33:03 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6031</guid>
		<description>Hey, the information is very useful.  Is nice that you emphasize that the H1N1 strain is not as deadly as for example H5N1. I see this event as a path to increase preparedness and response method futhermore ackwoledge that a pandemic can happen again and is a serious matter.</description>
		<content:encoded><![CDATA[<p>Hey, the information is very useful.  Is nice that you emphasize that the H1N1 strain is not as deadly as for example H5N1. I see this event as a path to increase preparedness and response method futhermore ackwoledge that a pandemic can happen again and is a serious matter.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr. Sairy Silva</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6029</link>
		<dc:creator>Dr. Sairy Silva</dc:creator>
		<pubDate>Wed, 02 Sep 2009 16:17:17 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6029</guid>
		<description>Dear Dr. Rossello,  Eventhough it is very difficult to obtain a vaccine as soon as is it needed and that the amount of vaccines available for the entire population is now out of the question, there is hope. First the protocols for who is going to received the first vaccines should be specific: high risk groups  and health professionals . Then , using those techniques you mentioned, and making it completely safe for public use , there  will be enough  to be given to   the entire public. 
Pandemic threats are just beginning. Keep it up.  Dr. Silva</description>
		<content:encoded><![CDATA[<p>Dear Dr. Rossello,  Eventhough it is very difficult to obtain a vaccine as soon as is it needed and that the amount of vaccines available for the entire population is now out of the question, there is hope. First the protocols for who is going to received the first vaccines should be specific: high risk groups  and health professionals . Then , using those techniques you mentioned, and making it completely safe for public use , there  will be enough  to be given to   the entire public.<br />
Pandemic threats are just beginning. Keep it up.  Dr. Silva</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Markos Stonka</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6024</link>
		<dc:creator>Markos Stonka</dc:creator>
		<pubDate>Wed, 02 Sep 2009 00:05:47 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6024</guid>
		<description>Insightful and useful article.  I had no idea what it took to generate vaccines.  No wonder it takes so much time... its a very old method!</description>
		<content:encoded><![CDATA[<p>Insightful and useful article.  I had no idea what it took to generate vaccines.  No wonder it takes so much time&#8230; its a very old method!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Yosem Companys</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6021</link>
		<dc:creator>Yosem Companys</dc:creator>
		<pubDate>Tue, 01 Sep 2009 14:55:44 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6021</guid>
		<description>Great article.  Hopefully, our decision makers will take action soon.</description>
		<content:encoded><![CDATA[<p>Great article.  Hopefully, our decision makers will take action soon.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bruce</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6019</link>
		<dc:creator>Bruce</dc:creator>
		<pubDate>Tue, 01 Sep 2009 01:35:22 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6019</guid>
		<description>Nice article Dr.

The US government needs to throw its full weight and resources behind Novavax and their VLP platform. Hope you can send the message along to those decision makers.</description>
		<content:encoded><![CDATA[<p>Nice article Dr.</p>
<p>The US government needs to throw its full weight and resources behind Novavax and their VLP platform. Hope you can send the message along to those decision makers.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Linda Wu</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6014</link>
		<dc:creator>Linda Wu</dc:creator>
		<pubDate>Mon, 31 Aug 2009 13:06:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6014</guid>
		<description>Virus like particles (VLPs) sounds very promising.  I wonder if they would need to produce different VLPs every season and what the time requirement is.</description>
		<content:encoded><![CDATA[<p>Virus like particles (VLPs) sounds very promising.  I wonder if they would need to produce different VLPs every season and what the time requirement is.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: John M.</title>
		<link>http://scienceprogress.org/2009/08/influenza-vaccine/comment-page-1/#comment-6011</link>
		<dc:creator>John M.</dc:creator>
		<pubDate>Mon, 31 Aug 2009 05:05:12 +0000</pubDate>
		<guid isPermaLink="false">http://www.scienceprogress.org/?p=4370#comment-6011</guid>
		<description>Very nice feature.  How soon will these alternative methods be ready?  Perhaps that can be the topic of another article (race against time).  Seems to me our policy makers should be focusing on expediting this process with funding.</description>
		<content:encoded><![CDATA[<p>Very nice feature.  How soon will these alternative methods be ready?  Perhaps that can be the topic of another article (race against time).  Seems to me our policy makers should be focusing on expediting this process with funding.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

